{"transactions":[{"id":4637051,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-07T20:17:57.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the \"Program\") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program."}],"balance_after":192571,"source":{"system":"sec-edgar","filing":"0001610717-26-000431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611115/000161071726000431/form4.xml","form_type":"4"}},{"id":706883,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:24:59.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":16377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options Granted on June 5, 2026 will become vested on the earlier of (i) June 5, 2027 or (ii) the business day prior to the 2027 annual meeting of shareholders."}],"balance_after":16377,"derivative":{"exercise_price":35.59,"exercise_date":"2027-06-02","expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":16377},"source":{"system":"sec-edgar","filing":"0001710072-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000171007226000001/primary_doc.xml","form_type":"4"}},{"id":713469,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T23:24:41.000Z","date":"2026-07-05","kind":"grant","planned":false,"acquired":true,"shares":820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the \"Program\") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program."}],"balance_after":191877,"source":{"system":"sec-edgar","filing":"0001610717-26-000323","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071726000323/form4.xml","form_type":"4"}},{"id":730229,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T10:02:01.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":13698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitutes an award of restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in full on the earlier of (i) the day before the Issuer's 2027 annual meeting of stockholders or (ii) June 3, 2027, subject, in all cases, to the Reporting Person's continued service as a member of the Board of Directors through such vesting date."}],"balance_after":497697,"source":{"system":"sec-edgar","filing":"0001193125-26-276601","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000119312526276601/ownership.xml","form_type":"4"}},{"id":731796,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-18T20:23:05.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":10882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will fully vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, subject to continued service through such vesting date."}],"balance_after":191057,"source":{"system":"sec-edgar","filing":"0001610717-26-000252","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071726000252/form4.xml","form_type":"4"}},{"id":813236,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-04-07T20:06:30.000Z","date":"2026-04-05","kind":"grant","planned":false,"acquired":true,"shares":882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the \"Program\") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program."}],"balance_after":180175,"source":{"system":"sec-edgar","filing":"0001610717-26-000142","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071726000142/form4.xml","form_type":"4"}},{"id":944179,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-07T22:37:28.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the \"Program\") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program."}],"balance_after":179293,"source":{"system":"sec-edgar","filing":"0001610717-26-000006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071726000006/form4.xml","form_type":"4"}},{"id":980096,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-04T22:56:05.000Z","date":"2025-12-02","kind":"other","planned":false,"acquired":false,"shares":146257,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata, in-kind distribution by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the \"USVP X Funds\"), without additional consideration, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by USVP X Affiliates, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of the USVP X Funds, has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001610717-25-000406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000406/form4.xml","form_type":"4"}},{"id":980095,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-04T22:56:05.000Z","date":"2025-12-02","kind":"other","planned":false,"acquired":false,"shares":4571769,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata, in-kind distribution by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the \"USVP X Funds\"), without additional consideration, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by U.S. Venture Partners X, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of the USVP X Funds, has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001610717-25-000406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000406/form4.xml","form_type":"4"}},{"id":980094,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-04T22:56:05.000Z","date":"2025-12-02","kind":"other","planned":false,"acquired":true,"shares":167748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata, in-kind distribution by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the \"USVP X Funds\"), without additional consideration, to its partners."}],"balance_after":178378,"source":{"system":"sec-edgar","filing":"0001610717-25-000406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000406/form4.xml","form_type":"4"}},{"id":1022023,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-07T20:42:40.000Z","date":"2025-10-05","kind":"grant","planned":false,"acquired":true,"shares":657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the \"Program\") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock."}],"balance_after":10630,"source":{"system":"sec-edgar","filing":"0001628280-25-044515","document":"wk-form4_1759869756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000162828025044515/wk-form4_1759869756.xml","form_type":"4"}},{"id":1081993,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2025-07-25T00:27:10.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":1117743,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Stock held by U.S. Venture Partners Select Fund I, L.P., (\"USVP SFI\") on its own behalf and as nominee for U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C (\"PMG SFI,\" and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1117743},"source":{"system":"sec-edgar","filing":"0000950170-25-098529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000095017025098529/ownership.xml","form_type":"4"}},{"id":1081992,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2025-07-25T00:27:10.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":26993,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Stock held by U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C (\"PMG SFI,\" and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":26993},"source":{"system":"sec-edgar","filing":"0000950170-25-098529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000095017025098529/ownership.xml","form_type":"4"}},{"id":1081991,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2025-07-25T00:27:10.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":41876,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Stock held by U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C (\"PMG SFI,\" and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":41876},"source":{"system":"sec-edgar","filing":"0000950170-25-098529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000095017025098529/ownership.xml","form_type":"4"}},{"id":1081990,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2025-07-25T00:27:10.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":149655,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Stock held by U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C (\"PMG SFI,\" and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":149655},"source":{"system":"sec-edgar","filing":"0000950170-25-098529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000095017025098529/ownership.xml","form_type":"4"}},{"id":1081989,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2025-07-25T00:27:10.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":531877,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C (\"PMG SFI,\" and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":531877},"source":{"system":"sec-edgar","filing":"0000950170-25-098529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000095017025098529/ownership.xml","form_type":"4"}},{"id":1081988,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2025-07-25T00:27:10.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":825135,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C (\"PMG SFI,\" and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":825135},"source":{"system":"sec-edgar","filing":"0000950170-25-098529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000095017025098529/ownership.xml","form_type":"4"}},{"id":1081987,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2025-07-25T00:27:10.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":2948794,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C (\"PMG SFI,\" and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2948794},"source":{"system":"sec-edgar","filing":"0000950170-25-098529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000095017025098529/ownership.xml","form_type":"4"}},{"id":1081986,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:27:10.000Z","date":"2025-07-24","kind":"purchase","planned":false,"acquired":true,"shares":466666,"price":15,"value":6999990.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"Includes 466,666 shares of the Issuer's common stock purchased by the Reporting Person in the Issuer's initial public offering at the public offering price of $15.00 per share. The purchase was made directly from the underwriters in connection with the offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Includes (i) 466,666 shares of the Issuer's common stock purchased by the reporting person in the Issuer's initial public offering at the public offering price of $15.00 per share, and (ii) 17,333 unvested RSUs convertible into approximately 17,333 shares of the Issuer's common stock. The RSUs will vest in equal annual installments over three years."}],"balance_after":483999,"source":{"system":"sec-edgar","filing":"0000950170-25-098529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000095017025098529/ownership.xml","form_type":"4"}},{"id":1081985,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:27:10.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":1117743,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Stock held by U.S. Venture Partners Select Fund I, L.P., (\"USVP SFI\") on its own behalf and as nominee for U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C (\"PMG SFI,\" and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein."}],"balance_after":1117743,"source":{"system":"sec-edgar","filing":"0000950170-25-098529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000095017025098529/ownership.xml","form_type":"4"}},{"id":1081984,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:27:10.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":26993,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Stock held by U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C (\"PMG SFI,\" and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein."}],"balance_after":218524,"source":{"system":"sec-edgar","filing":"0000950170-25-098529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000095017025098529/ownership.xml","form_type":"4"}},{"id":1081983,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:27:10.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":41876,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Stock held by U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C (\"PMG SFI,\" and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein."}],"balance_after":191531,"source":{"system":"sec-edgar","filing":"0000950170-25-098529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000095017025098529/ownership.xml","form_type":"4"}},{"id":1081982,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:27:10.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":149655,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Stock held by U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C (\"PMG SFI,\" and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein."}],"balance_after":149655,"source":{"system":"sec-edgar","filing":"0000950170-25-098529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000095017025098529/ownership.xml","form_type":"4"}},{"id":1081981,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:27:10.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":531877,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C (\"PMG SFI,\" and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein."}],"balance_after":4305806,"source":{"system":"sec-edgar","filing":"0000950170-25-098529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000095017025098529/ownership.xml","form_type":"4"}},{"id":1081980,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:27:10.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":825135,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C (\"PMG SFI,\" and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein."}],"balance_after":3773929,"source":{"system":"sec-edgar","filing":"0000950170-25-098529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000095017025098529/ownership.xml","form_type":"4"}},{"id":1081979,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:27:10.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":2948794,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C (\"PMG SFI,\" and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein."}],"balance_after":2948794,"source":{"system":"sec-edgar","filing":"0000950170-25-098529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000095017025098529/ownership.xml","form_type":"4"}},{"id":1081978,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:27:10.000Z","date":"2025-07-22","kind":"grant","planned":false,"acquired":true,"shares":17333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute an award of restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in equal annual installments over three years."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 17,333 unvested restricted stock units convertible into approximately 17,333 shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Constitute an award of restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in equal annual installments over three years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 17,333 unvested restricted stock units convertible into approximately 17,333 shares of the Issuer's common stock."}],"balance_after":17333,"source":{"system":"sec-edgar","filing":"0000950170-25-098529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000095017025098529/ownership.xml","form_type":"4"}},{"id":1090512,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-08T20:15:30.000Z","date":"2025-07-05","kind":"grant","planned":false,"acquired":true,"shares":237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the \"Program\") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock."}],"balance_after":9973,"source":{"system":"sec-edgar","filing":"0001610717-25-000278","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000278/form4.xml","form_type":"4"}},{"id":1106347,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T23:36:27.000Z","date":"2025-06-16","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 16, 2025 will become vested on the earlier of (i) June 16, 2026 or (ii) the business day prior to the 2026 annual meeting of stockholders."}],"balance_after":30000,"derivative":{"exercise_price":14.68,"exercise_date":"2026-06-16","expiration_date":"2035-06-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-25-004957","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025004957/primarydocument.xml","form_type":"4"}},{"id":1117574,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Series D Preferred Stock","published_at":"2025-06-09T20:20:57.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":false,"shares":10690,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by USVP X Affiliates, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10690},"source":{"system":"sec-edgar","filing":"0001610717-25-000185","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000185/form4.xml","form_type":"4"}},{"id":1117573,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Series C-1 Preferred Stock","published_at":"2025-06-09T20:20:57.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":false,"shares":8283,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by USVP X Affiliates, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8283},"source":{"system":"sec-edgar","filing":"0001610717-25-000185","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000185/form4.xml","form_type":"4"}},{"id":1117572,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Series C Preferred Stock","published_at":"2025-06-09T20:20:57.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":false,"shares":11434,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by USVP X Affiliates, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11434},"source":{"system":"sec-edgar","filing":"0001610717-25-000185","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000185/form4.xml","form_type":"4"}},{"id":1117571,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Series B Preferred Stock","published_at":"2025-06-09T20:20:57.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":false,"shares":56786,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by USVP X Affiliates, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":56786},"source":{"system":"sec-edgar","filing":"0001610717-25-000185","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000185/form4.xml","form_type":"4"}},{"id":1117570,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Series A Preferred Stock","published_at":"2025-06-09T20:20:57.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":false,"shares":58030,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by USVP X Affiliates, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":58030},"source":{"system":"sec-edgar","filing":"0001610717-25-000185","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000185/form4.xml","form_type":"4"}},{"id":1117569,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Series D Preferred Stock","published_at":"2025-06-09T20:20:57.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":false,"shares":334151,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by U.S. Venture Partners X, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":334151},"source":{"system":"sec-edgar","filing":"0001610717-25-000185","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000185/form4.xml","form_type":"4"}},{"id":1117568,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Series C-1 Preferred Stock","published_at":"2025-06-09T20:20:57.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":false,"shares":258931,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by U.S. Venture Partners X, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":258931},"source":{"system":"sec-edgar","filing":"0001610717-25-000185","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000185/form4.xml","form_type":"4"}},{"id":1117567,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Series C Preferred Stock","published_at":"2025-06-09T20:20:57.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":false,"shares":357402,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by U.S. Venture Partners X, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":357402},"source":{"system":"sec-edgar","filing":"0001610717-25-000185","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000185/form4.xml","form_type":"4"}},{"id":1117566,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Series B Preferred Stock","published_at":"2025-06-09T20:20:57.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":false,"shares":1775025,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by U.S. Venture Partners X, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1775025},"source":{"system":"sec-edgar","filing":"0001610717-25-000185","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000185/form4.xml","form_type":"4"}},{"id":1117565,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Series A Preferred Stock","published_at":"2025-06-09T20:20:57.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":false,"shares":1813927,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by U.S. Venture Partners X, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1813927},"source":{"system":"sec-edgar","filing":"0001610717-25-000185","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000185/form4.xml","form_type":"4"}},{"id":1117564,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-09T20:20:57.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":true,"shares":145223,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by USVP X Affiliates, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":146257,"source":{"system":"sec-edgar","filing":"0001610717-25-000185","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000185/form4.xml","form_type":"4"}},{"id":1117563,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-09T20:20:57.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":true,"shares":4539436,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by U.S. Venture Partners X, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":4571769,"source":{"system":"sec-edgar","filing":"0001610717-25-000185","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000185/form4.xml","form_type":"4"}},{"id":1117562,"issuer":{"id":2364,"kind":"organization","name":"Omada Health, Inc.","symbol":"OMDA"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-09T20:20:57.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":9736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will fully vest on the first anniversary of June 5, 2025."}],"balance_after":9736,"source":{"system":"sec-edgar","filing":"0001610717-25-000185","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000161071725000185/form4.xml","form_type":"4"}},{"id":1259150,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-20T01:14:58.000Z","date":"2025-02-19","kind":"other","planned":false,"acquired":false,"shares":335,"ownership":{"direct":false,"nature":"Directly Owned by Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-25-005749","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000112760225005749/form4.xml","form_type":"4"}},{"id":1259149,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-20T01:14:58.000Z","date":"2025-02-19","kind":"other","planned":false,"acquired":false,"shares":541149,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 4,126 restricted stock units (\"RSUs\"). At the Effective Time, each outstanding award of RSUs was canceled and converted into the right to receive an amount in cash equal to the product of the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time, multiplied by the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-25-005749","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000112760225005749/form4.xml","form_type":"4"}},{"id":1482126,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-12T23:22:48.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":20594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 10, 2024 will become vested on the earlier of (i) June 10, 2025 or (ii) the business day prior to the date of the 2025 annual meeting of stockholders."}],"balance_after":20594,"derivative":{"exercise_price":17.13,"exercise_date":"2025-06-10","expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":20594},"source":{"system":"sec-edgar","filing":"0001562180-24-005017","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024005017/primarydocument.xml","form_type":"4"}},{"id":1496416,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-31T20:58:03.000Z","date":"2024-04-24","kind":"grant","planned":false,"acquired":true,"shares":4126,"price":42.41,"value":174983.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on April 24, 2024 to the Reporting Person that vest in full on the earlier of (1) the day prior to the Issuer's next annual meeting of stockholders or (2) one year from the date of grant."}],"balance_after":541149,"source":{"system":"sec-edgar","filing":"0001127602-24-017132","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000112760224017132/form4a.xml","form_type":"4/A","original_submission_date":"2024-04-26"}},{"id":1534623,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-26T20:56:56.000Z","date":"2024-04-24","kind":"grant","planned":false,"acquired":true,"shares":4126,"price":42.41,"value":174983.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on April 24, 2024 to the Reporting Person that vest in full on the earlier of (1) the day prior to the Issuer's next annual meeting of stockholders or (2) one year from the date of grant."}],"balance_after":541149,"source":{"system":"sec-edgar","filing":"0001127602-24-013476","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000112760224013476/form4.xml","form_type":"4"}},{"id":1855948,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-14T23:29:32.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":22123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 12, 2023 will become vested on the earlier of (i) June 12, 2024 or (ii) the business day prior to the date of the 2024 annual meeting of stockholders."}],"balance_after":22123,"derivative":{"exercise_price":9.55,"exercise_date":"2024-06-12","expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":22123},"source":{"system":"sec-edgar","filing":"0001562180-23-005176","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023005176/primarydocument.xml","form_type":"4"}},{"id":1874471,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2023-05-30T20:37:17.000Z","date":"2023-05-27","kind":"exercise","planned":false,"acquired":false,"shares":2982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") which represent a contingent right to receive one share of common stock for each RSU.  1/3 of the RSUs vested on May 27,2021, and the remaining RSUs will vest annually thereafter over the next two years."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") which represent a contingent right to receive one share of common stock for each RSU.  1/3 of the RSUs vested on May 27,2021, and the remaining RSUs will vest annually thereafter over the next two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") which represent a contingent right to receive one share of common stock for each RSU.  1/3 of the RSUs vested on May 27,2021, and the remaining RSUs will vest annually thereafter over the next two years."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2982},"source":{"system":"sec-edgar","filing":"0001127602-23-017039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000112760223017039/form4.xml","form_type":"4"}},{"id":1874470,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-30T20:37:17.000Z","date":"2023-05-27","kind":"exercise","planned":false,"acquired":true,"shares":2982,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":537023,"source":{"system":"sec-edgar","filing":"0001127602-23-017039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000112760223017039/form4.xml","form_type":"4"}},{"id":1884255,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-19T22:05:58.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":2412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSUs granted on May 18, 2023, to the Reporting Person that vest in full on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the 2024 annual meeting."}],"balance_after":534041,"source":{"system":"sec-edgar","filing":"0001127602-23-016353","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000112760223016353/form4.xml","form_type":"4"}},{"id":2195686,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-03T21:58:50.000Z","date":"2022-08-03","kind":"sale","acquired":false,"shares":1796,"price":0.804,"value":1443.984,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.81, inclusive for sales on 8/1/22; prices ranging from $0.78 to $0.83, inclusive for sales on 8/2/22; and prices ranging from $0.79 to $0.83, inclusive for sales on 8/3/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":127569,"source":{"system":"sec-edgar","filing":"0001062993-22-017215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322017215/form4.xml","form_type":"4"}},{"id":2195685,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-03T21:58:50.000Z","date":"2022-08-03","kind":"sale","acquired":false,"shares":57580,"price":0.804,"value":46294.32,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.81, inclusive for sales on 8/1/22; prices ranging from $0.78 to $0.83, inclusive for sales on 8/2/22; and prices ranging from $0.79 to $0.83, inclusive for sales on 8/3/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":3981940,"source":{"system":"sec-edgar","filing":"0001062993-22-017215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322017215/form4.xml","form_type":"4"}},{"id":2195684,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-03T21:58:50.000Z","date":"2022-08-02","kind":"sale","acquired":false,"shares":853,"price":0.797,"value":679.841,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.81, inclusive for sales on 8/1/22; prices ranging from $0.78 to $0.83, inclusive for sales on 8/2/22; and prices ranging from $0.79 to $0.83, inclusive for sales on 8/3/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":129365,"source":{"system":"sec-edgar","filing":"0001062993-22-017215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322017215/form4.xml","form_type":"4"}},{"id":2195683,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-03T21:58:50.000Z","date":"2022-08-02","kind":"sale","acquired":false,"shares":27348,"price":0.797,"value":21796.356,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.81, inclusive for sales on 8/1/22; prices ranging from $0.78 to $0.83, inclusive for sales on 8/2/22; and prices ranging from $0.79 to $0.83, inclusive for sales on 8/3/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4039520,"source":{"system":"sec-edgar","filing":"0001062993-22-017215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322017215/form4.xml","form_type":"4"}},{"id":2195682,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-03T21:58:50.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":807,"price":0.786,"value":634.302,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.81, inclusive for sales on 8/1/22; prices ranging from $0.78 to $0.83, inclusive for sales on 8/2/22; and prices ranging from $0.79 to $0.83, inclusive for sales on 8/3/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":130218,"source":{"system":"sec-edgar","filing":"0001062993-22-017215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322017215/form4.xml","form_type":"4"}},{"id":2195681,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-03T21:58:50.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":25896,"price":0.786,"value":20354.256,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.81, inclusive for sales on 8/1/22; prices ranging from $0.78 to $0.83, inclusive for sales on 8/2/22; and prices ranging from $0.79 to $0.83, inclusive for sales on 8/3/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4066868,"source":{"system":"sec-edgar","filing":"0001062993-22-017215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322017215/form4.xml","form_type":"4"}},{"id":2200179,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-30T00:54:43.000Z","date":"2022-07-28","kind":"sale","acquired":false,"shares":984,"price":0.892,"value":877.728,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.89 to $0.91, inclusive for sales on 7/28/22. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":131025,"source":{"system":"sec-edgar","filing":"0001062993-22-016924","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016924/form4.xml","form_type":"4"}},{"id":2200178,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-30T00:54:43.000Z","date":"2022-07-28","kind":"sale","acquired":false,"shares":31533,"price":0.892,"value":28127.436,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.89 to $0.91, inclusive for sales on 7/28/22. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4092764,"source":{"system":"sec-edgar","filing":"0001062993-22-016924","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016924/form4.xml","form_type":"4"}},{"id":2201315,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-27T22:20:11.000Z","date":"2022-07-27","kind":"sale","acquired":false,"shares":1321,"price":0.892,"value":1178.332,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.91 to $0.95, inclusive for sales on 7/25/22; prices ranging from $0.90 to $0.91, inclusive for sales on 7/26/22; and prices ranging from $0.89 to $0.91, inclusive for sales on 7/27/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":132009,"source":{"system":"sec-edgar","filing":"0001062993-22-016802","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016802/form4.xml","form_type":"4"}},{"id":2201314,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-27T22:20:11.000Z","date":"2022-07-27","kind":"sale","acquired":false,"shares":42344,"price":0.892,"value":37770.848,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.91 to $0.95, inclusive for sales on 7/25/22; prices ranging from $0.90 to $0.91, inclusive for sales on 7/26/22; and prices ranging from $0.89 to $0.91, inclusive for sales on 7/27/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4124297,"source":{"system":"sec-edgar","filing":"0001062993-22-016802","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016802/form4.xml","form_type":"4"}},{"id":2201313,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-27T22:20:11.000Z","date":"2022-07-26","kind":"sale","acquired":false,"shares":84,"price":0.904,"value":75.936,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.91 to $0.95, inclusive for sales on 7/25/22; prices ranging from $0.90 to $0.91, inclusive for sales on 7/26/22; and prices ranging from $0.89 to $0.91, inclusive for sales on 7/27/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":133330,"source":{"system":"sec-edgar","filing":"0001062993-22-016802","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016802/form4.xml","form_type":"4"}},{"id":2201312,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-27T22:20:11.000Z","date":"2022-07-26","kind":"sale","acquired":false,"shares":2691,"price":0.904,"value":2432.664,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.91 to $0.95, inclusive for sales on 7/25/22; prices ranging from $0.90 to $0.91, inclusive for sales on 7/26/22; and prices ranging from $0.89 to $0.91, inclusive for sales on 7/27/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4166641,"source":{"system":"sec-edgar","filing":"0001062993-22-016802","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016802/form4.xml","form_type":"4"}},{"id":2201311,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-27T22:20:11.000Z","date":"2022-07-25","kind":"sale","acquired":false,"shares":69,"price":0.931,"value":64.239,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.91 to $0.95, inclusive for sales on 7/25/22; prices ranging from $0.90 to $0.91, inclusive for sales on 7/26/22; and prices ranging from $0.89 to $0.91, inclusive for sales on 7/27/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":133414,"source":{"system":"sec-edgar","filing":"0001062993-22-016802","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016802/form4.xml","form_type":"4"}},{"id":2201310,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-27T22:20:11.000Z","date":"2022-07-25","kind":"sale","acquired":false,"shares":2210,"price":0.931,"value":2057.51,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.91 to $0.95, inclusive for sales on 7/25/22; prices ranging from $0.90 to $0.91, inclusive for sales on 7/26/22; and prices ranging from $0.89 to $0.91, inclusive for sales on 7/27/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4169332,"source":{"system":"sec-edgar","filing":"0001062993-22-016802","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016802/form4.xml","form_type":"4"}},{"id":2203252,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-22T22:03:17.000Z","date":"2022-07-22","kind":"sale","acquired":false,"shares":231,"price":0.911,"value":210.441,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.02, inclusive for sales on 7/20/22; prices ranging from $0.94 to $1.00, inclusive for sales on 7/21/22; and prices ranging from $0.91 to $0.94, inclusive for sales on 7/22/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":133483,"source":{"system":"sec-edgar","filing":"0001062993-22-016678","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016678/form4.xml","form_type":"4"}},{"id":2203251,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-22T22:03:17.000Z","date":"2022-07-22","kind":"sale","acquired":false,"shares":7383,"price":0.91,"value":6718.53,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.02, inclusive for sales on 7/20/22; prices ranging from $0.94 to $1.00, inclusive for sales on 7/21/22; and prices ranging from $0.91 to $0.94, inclusive for sales on 7/22/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4171542,"source":{"system":"sec-edgar","filing":"0001062993-22-016678","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016678/form4.xml","form_type":"4"}},{"id":2203250,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-22T22:03:17.000Z","date":"2022-07-21","kind":"sale","acquired":false,"shares":81,"price":0.956,"value":77.436,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.02, inclusive for sales on 7/20/22; prices ranging from $0.94 to $1.00, inclusive for sales on 7/21/22; and prices ranging from $0.91 to $0.94, inclusive for sales on 7/22/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":133714,"source":{"system":"sec-edgar","filing":"0001062993-22-016678","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016678/form4.xml","form_type":"4"}},{"id":2203249,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-22T22:03:17.000Z","date":"2022-07-21","kind":"sale","acquired":false,"shares":2584,"price":0.955,"value":2467.72,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.02, inclusive for sales on 7/20/22; prices ranging from $0.94 to $1.00, inclusive for sales on 7/21/22; and prices ranging from $0.91 to $0.94, inclusive for sales on 7/22/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4178925,"source":{"system":"sec-edgar","filing":"0001062993-22-016678","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016678/form4.xml","form_type":"4"}},{"id":2203248,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-22T22:03:17.000Z","date":"2022-07-20","kind":"sale","acquired":false,"shares":304,"price":1.001,"value":304.304,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.02, inclusive for sales on 7/20/22; prices ranging from $0.94 to $1.00, inclusive for sales on 7/21/22; and prices ranging from $0.91 to $0.94, inclusive for sales on 7/22/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":133795,"source":{"system":"sec-edgar","filing":"0001062993-22-016678","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016678/form4.xml","form_type":"4"}},{"id":2203247,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-22T22:03:17.000Z","date":"2022-07-20","kind":"sale","acquired":false,"shares":9726,"price":1.001,"value":9735.726,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.02, inclusive for sales on 7/20/22; prices ranging from $0.94 to $1.00, inclusive for sales on 7/21/22; and prices ranging from $0.91 to $0.94, inclusive for sales on 7/22/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4181509,"source":{"system":"sec-edgar","filing":"0001062993-22-016678","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016678/form4.xml","form_type":"4"}},{"id":2205308,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-19T20:54:40.000Z","date":"2022-07-19","kind":"sale","acquired":false,"shares":84,"price":1,"value":84.0,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.10 to $1.14, inclusive for sales on 7/15/22; prices ranging from $1.00 to $1.15, inclusive for sales on 7/18/22; and prices ranging from $1.00 to $1.00, inclusive for sales on 7/19/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":134099,"source":{"system":"sec-edgar","filing":"0001062993-22-016514","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016514/form4.xml","form_type":"4"}},{"id":2205307,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-19T20:54:40.000Z","date":"2022-07-19","kind":"sale","acquired":false,"shares":2670,"price":1,"value":2670.0,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.10 to $1.14, inclusive for sales on 7/15/22; prices ranging from $1.00 to $1.15, inclusive for sales on 7/18/22; and prices ranging from $1.00 to $1.00, inclusive for sales on 7/19/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4191235,"source":{"system":"sec-edgar","filing":"0001062993-22-016514","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016514/form4.xml","form_type":"4"}},{"id":2205306,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-19T20:54:40.000Z","date":"2022-07-18","kind":"sale","acquired":false,"shares":635,"price":1.081,"value":686.435,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.10 to $1.14, inclusive for sales on 7/15/22; prices ranging from $1.00 to $1.15, inclusive for sales on 7/18/22; and prices ranging from $1.00 to $1.00, inclusive for sales on 7/19/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":134183,"source":{"system":"sec-edgar","filing":"0001062993-22-016514","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016514/form4.xml","form_type":"4"}},{"id":2205305,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-19T20:54:40.000Z","date":"2022-07-18","kind":"sale","acquired":false,"shares":20352,"price":1.08,"value":21980.16,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.10 to $1.14, inclusive for sales on 7/15/22; prices ranging from $1.00 to $1.15, inclusive for sales on 7/18/22; and prices ranging from $1.00 to $1.00, inclusive for sales on 7/19/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4193905,"source":{"system":"sec-edgar","filing":"0001062993-22-016514","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016514/form4.xml","form_type":"4"}},{"id":2205304,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-19T20:54:40.000Z","date":"2022-07-15","kind":"sale","acquired":false,"shares":1423,"price":1.108,"value":1576.684,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.10 to $1.14, inclusive for sales on 7/15/22; prices ranging from $1.00 to $1.15, inclusive for sales on 7/18/22; and prices ranging from $1.00 to $1.00, inclusive for sales on 7/19/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":134818,"source":{"system":"sec-edgar","filing":"0001062993-22-016514","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016514/form4.xml","form_type":"4"}},{"id":2205303,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-19T20:54:40.000Z","date":"2022-07-15","kind":"sale","acquired":false,"shares":44477,"price":1.108,"value":49280.516,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.10 to $1.14, inclusive for sales on 7/15/22; prices ranging from $1.00 to $1.15, inclusive for sales on 7/18/22; and prices ranging from $1.00 to $1.00, inclusive for sales on 7/19/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4214257,"source":{"system":"sec-edgar","filing":"0001062993-22-016514","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016514/form4.xml","form_type":"4"}},{"id":2220193,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-28T23:16:58.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":42087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 24, 2022 will become vested on the earlier of (i) June 24, 2023 or (ii) the business day prior to the date of the 2023 annual meeting of stockholders."}],"balance_after":42087,"derivative":{"exercise_price":8.53,"exercise_date":"2023-06-08","expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":42087},"source":{"system":"sec-edgar","filing":"0001562180-22-005385","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005385/primarydocument.xml","form_type":"4"}},{"id":2234180,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T23:48:06.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest on the earlier of June 10, 2023 or the date of the Issuer's 2023 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors."}],"balance_after":18000,"derivative":{"exercise_price":4.18,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-22-036478","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122036478/doc4.xml","form_type":"4"}},{"id":2252979,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2022-05-27T20:26:57.000Z","date":"2022-05-27","kind":"exercise","acquired":false,"shares":2983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\") which represent a contingent right to receive one share of common stock for each RSU.  1/3 of the RSUs vested on May 27,2021, and the remaining RSUs will vest annually thereafter over the next two years."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\") which represent a contingent right to receive one share of common stock for each RSU.  1/3 of the RSUs vested on May 27,2021, and the remaining RSUs will vest annually thereafter over the next two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\") which represent a contingent right to receive one share of common stock for each RSU.  1/3 of the RSUs vested on May 27,2021, and the remaining RSUs will vest annually thereafter over the next two years."}],"balance_after":2982,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2983},"source":{"system":"sec-edgar","filing":"0001127602-22-015861","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000112760222015861/form4.xml","form_type":"4"}},{"id":2252978,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-27T20:26:57.000Z","date":"2022-05-27","kind":"exercise","acquired":true,"shares":2983,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":531629,"source":{"system":"sec-edgar","filing":"0001127602-22-015861","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000112760222015861/form4.xml","form_type":"4"}},{"id":2252977,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":1,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-27T20:26:57.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":2420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSUs granted on May 26, 2022, to the Reporting Person that vest in full on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the 2023 annual meeting."}],"balance_after":528646,"source":{"system":"sec-edgar","filing":"0001127602-22-015861","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225480/000112760222015861/form4.xml","form_type":"4"}},{"id":2263644,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-19T22:16:46.000Z","date":"2022-05-19","kind":"sale","acquired":false,"shares":266,"price":1.689,"value":449.274,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.82, inclusive for sales on 5/17/22; prices ranging from $1.70 to $1.93, inclusive for sales on 5/18/22; and prices ranging from $1.63 to $1.78, inclusive for sales on 5/19/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":136241,"source":{"system":"sec-edgar","filing":"0001062993-22-013050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322013050/form4.xml","form_type":"4"}},{"id":2263643,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-19T22:16:46.000Z","date":"2022-05-19","kind":"sale","acquired":false,"shares":8308,"price":1.69,"value":14040.52,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.82, inclusive for sales on 5/17/22; prices ranging from $1.70 to $1.93, inclusive for sales on 5/18/22; and prices ranging from $1.63 to $1.78, inclusive for sales on 5/19/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4258734,"source":{"system":"sec-edgar","filing":"0001062993-22-013050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322013050/form4.xml","form_type":"4"}},{"id":2263642,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-19T22:16:46.000Z","date":"2022-05-18","kind":"sale","acquired":false,"shares":437,"price":1.734,"value":757.758,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.82, inclusive for sales on 5/17/22; prices ranging from $1.70 to $1.93, inclusive for sales on 5/18/22; and prices ranging from $1.63 to $1.78, inclusive for sales on 5/19/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":136507,"source":{"system":"sec-edgar","filing":"0001062993-22-013050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322013050/form4.xml","form_type":"4"}},{"id":2263641,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-19T22:16:46.000Z","date":"2022-05-18","kind":"sale","acquired":false,"shares":13649,"price":1.734,"value":23667.366,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.82, inclusive for sales on 5/17/22; prices ranging from $1.70 to $1.93, inclusive for sales on 5/18/22; and prices ranging from $1.63 to $1.78, inclusive for sales on 5/19/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4267042,"source":{"system":"sec-edgar","filing":"0001062993-22-013050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322013050/form4.xml","form_type":"4"}},{"id":2263640,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-19T22:16:46.000Z","date":"2022-05-17","kind":"sale","acquired":false,"shares":365,"price":1.75,"value":638.75,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.82, inclusive for sales on 5/17/22; prices ranging from $1.70 to $1.93, inclusive for sales on 5/18/22; and prices ranging from $1.63 to $1.78, inclusive for sales on 5/19/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":136944,"source":{"system":"sec-edgar","filing":"0001062993-22-013050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322013050/form4.xml","form_type":"4"}},{"id":2263639,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-19T22:16:46.000Z","date":"2022-05-17","kind":"sale","acquired":false,"shares":11402,"price":1.749,"value":19942.098,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.82, inclusive for sales on 5/17/22; prices ranging from $1.70 to $1.93, inclusive for sales on 5/18/22; and prices ranging from $1.63 to $1.78, inclusive for sales on 5/19/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4280691,"source":{"system":"sec-edgar","filing":"0001062993-22-013050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322013050/form4.xml","form_type":"4"}},{"id":2270245,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T22:36:05.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":395,"price":1.746,"value":689.67,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.98 to $2.02, inclusive for sales on 5/12/22; prices ranging from $1.80 to $1.97, inclusive for sales on 5/13/22; and prices ranging from $1.65 to $1.80, inclusive for sales on 5/16/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":137309,"source":{"system":"sec-edgar","filing":"0001062993-22-012659","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322012659/form4.xml","form_type":"4"}},{"id":2270244,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T22:36:05.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":12374,"price":1.746,"value":21605.004,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.98 to $2.02, inclusive for sales on 5/12/22; prices ranging from $1.80 to $1.97, inclusive for sales on 5/13/22; and prices ranging from $1.65 to $1.80, inclusive for sales on 5/16/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4292093,"source":{"system":"sec-edgar","filing":"0001062993-22-012659","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322012659/form4.xml","form_type":"4"}},{"id":2270243,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T22:36:05.000Z","date":"2022-05-13","kind":"sale","acquired":false,"shares":701,"price":1.839,"value":1289.139,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.98 to $2.02, inclusive for sales on 5/12/22; prices ranging from $1.80 to $1.97, inclusive for sales on 5/13/22; and prices ranging from $1.65 to $1.80, inclusive for sales on 5/16/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":137704,"source":{"system":"sec-edgar","filing":"0001062993-22-012659","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322012659/form4.xml","form_type":"4"}},{"id":2270242,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T22:36:05.000Z","date":"2022-05-13","kind":"sale","acquired":false,"shares":21906,"price":1.839,"value":40285.134,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.98 to $2.02, inclusive for sales on 5/12/22; prices ranging from $1.80 to $1.97, inclusive for sales on 5/13/22; and prices ranging from $1.65 to $1.80, inclusive for sales on 5/16/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4304467,"source":{"system":"sec-edgar","filing":"0001062993-22-012659","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322012659/form4.xml","form_type":"4"}},{"id":2270241,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T22:36:05.000Z","date":"2022-05-12","kind":"sale","acquired":false,"shares":336,"price":2.003,"value":673.008,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.98 to $2.02, inclusive for sales on 5/12/22; prices ranging from $1.80 to $1.97, inclusive for sales on 5/13/22; and prices ranging from $1.65 to $1.80, inclusive for sales on 5/16/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":138405,"source":{"system":"sec-edgar","filing":"0001062993-22-012659","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322012659/form4.xml","form_type":"4"}},{"id":2270240,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T22:36:05.000Z","date":"2022-05-12","kind":"sale","acquired":false,"shares":10464,"price":2.003,"value":20959.392,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.98 to $2.02, inclusive for sales on 5/12/22; prices ranging from $1.80 to $1.97, inclusive for sales on 5/13/22; and prices ranging from $1.65 to $1.80, inclusive for sales on 5/16/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4326373,"source":{"system":"sec-edgar","filing":"0001062993-22-012659","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322012659/form4.xml","form_type":"4"}},{"id":2274733,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-12T00:10:46.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":155,"price":2.346,"value":363.63,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.43 to $2.61, inclusive for sales on 5/9/22; prices ranging from $2.40 to $2.45, inclusive for sales on 5/10/22; and prices ranging from $2.14 to $2.40, inclusive for sales on 5/11/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":138741,"source":{"system":"sec-edgar","filing":"0001062993-22-012169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322012169/form4.xml","form_type":"4"}},{"id":2274732,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-12T00:10:46.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":4845,"price":2.345,"value":11361.525,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.43 to $2.61, inclusive for sales on 5/9/22; prices ranging from $2.40 to $2.45, inclusive for sales on 5/10/22; and prices ranging from $2.14 to $2.40, inclusive for sales on 5/11/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4336837,"source":{"system":"sec-edgar","filing":"0001062993-22-012169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322012169/form4.xml","form_type":"4"}},{"id":2274731,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-12T00:10:46.000Z","date":"2022-05-10","kind":"sale","acquired":false,"shares":1241,"price":2.413,"value":2994.533,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.43 to $2.61, inclusive for sales on 5/9/22; prices ranging from $2.40 to $2.45, inclusive for sales on 5/10/22; and prices ranging from $2.14 to $2.40, inclusive for sales on 5/11/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":138896,"source":{"system":"sec-edgar","filing":"0001062993-22-012169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322012169/form4.xml","form_type":"4"}},{"id":2274730,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-12T00:10:46.000Z","date":"2022-05-10","kind":"sale","acquired":false,"shares":38743,"price":2.413,"value":93486.859,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.43 to $2.61, inclusive for sales on 5/9/22; prices ranging from $2.40 to $2.45, inclusive for sales on 5/10/22; and prices ranging from $2.14 to $2.40, inclusive for sales on 5/11/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4341682,"source":{"system":"sec-edgar","filing":"0001062993-22-012169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322012169/form4.xml","form_type":"4"}},{"id":2274729,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-12T00:10:46.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":124,"price":2.537,"value":314.588,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.43 to $2.61, inclusive for sales on 5/9/22; prices ranging from $2.40 to $2.45, inclusive for sales on 5/10/22; and prices ranging from $2.14 to $2.40, inclusive for sales on 5/11/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":140137,"source":{"system":"sec-edgar","filing":"0001062993-22-012169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322012169/form4.xml","form_type":"4"}},{"id":2274728,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-12T00:10:46.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":3876,"price":2.536,"value":9829.536,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.43 to $2.61, inclusive for sales on 5/9/22; prices ranging from $2.40 to $2.45, inclusive for sales on 5/10/22; and prices ranging from $2.14 to $2.40, inclusive for sales on 5/11/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4380425,"source":{"system":"sec-edgar","filing":"0001062993-22-012169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322012169/form4.xml","form_type":"4"}}],"next_cursor":"2022-05-12T00:10:46.000000Z,2274728"}